Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

"I think we were contrarians,” Sanofi's chief digital officer Emmanuel Frenehard told Fortune. “I think the contrarians are ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR – Research ...

The global small-molecule injectable market is poised for significant growth, with an estimated valuation of USD 65.10 ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

In cases involving unpredictable factors, such as most chemical reactions, pharmaceutical activity, and physiological ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

Learn about the legal battle between Bristol Myers Squibb and the HHS over the 340B drug pricing program, as other drugmakers join in with rebate plans.

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...

The microbial therapeutic products market is forecast to grow from USD 17.11 billion in 2022 to USD 30.55 billion by 2030, ...

A new experimental weight loss drug from Amgen — the first in a growing group of drugs aimed at once-a-month injections instead of once a week — helped patients lose up to 20% of their weight in one ...

The World Bank’s ‘one stop shop’ bid to up investment. Plus, we list down the Inter-American Development Bank's top 10 ...